Back to search

Article

Progesterone in Addition to Standard of Care Versus Standard of Care Alone in the Treatment of Men Admitted to the Hospital with Moderate to Severe COVID-19: A Randomised Control Phase 1 Trial

2020-10-13

Abstract excerpt

Background: Severity of illness and mortality from coronavirus disease 2019 (COVID-19) is consistently lower in women than in men. While this outcome difference is not well understood, focus on sex as a biologic factor may suggest potential therapeutic intervention for this disease. We assessed whether adding progesterone, a steroid hormone with immune-modulatory properties, to standard of care, would improve clin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e95022b7-b0b8-57fa-bb6b-2e4a8512aeac
DOI
10.2139/ssrn.3709835
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Progesterone in Addition to Standard of Care Versus Standard of Care Alone in the Treatment of Men Admitted to the Hospital with Moderate to Severe COVID-19: A Randomised Control Phase 1 TrialDOI 10.2139/ssrn.3709835
Sex difference in the cytokine profile among patients hospitalized for COVID-19 and during their recovery: predominance of females in adhesion molecules and males in oxidative stressSemantic proximity
Clinical update on COVID ‐19 in pregnancy: A review articleSemantic proximity
Obstetric Management of COVID-19 in Pregnant WomenSemantic proximity
Sex-specific causal effects of serum sex hormones on COVID-19 susceptibility and severity: evidence from the UK Biobank and COVID-19 Host Genetics InitiativeSemantic proximity
Sex-specific causal effects of serum sex hormones on COVID-19 susceptibility and severity: evidence from the UK Biobank and COVID-19 Host Genetics InitiativeSemantic proximity
An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female TrialSemantic proximity
COVID-19 outcomes in hospitalized puerperal, pregnant, and neither pregnant nor puerperal women: a population studySemantic proximity
What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses.Semantic proximity
Effect of Maraviroc and/or Favipiravir plus systemic steroids versus systemic steroids only on the viral load of adults with severe COVID-19: clinical trialSemantic proximity
Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity.Semantic proximity
Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysisSemantic proximity
Anti-Androgen and Anti-Hypoxia Treatment for Severe COVID-19 PatientsSemantic proximity
Select a neighboring publication to make it the new centre.